Brancaccio John P's Form 4 filing
OKYO Pharma Ltd (OKYO) · filed Sep 28, 2023
- Accession no.
- 0001493152-23-034486
- Filed
- Sep 28, 2023
- Trade date
- Sep 15, 2023
- Filing delay
- 13 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $25.0K. It was filed 13 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brancaccio John PCIK 0001276551 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Ordinary Shares | PPurchaseAcquired | +16,670 | $1.50 | +$25,005 | 16,670 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.